Search

everythinglearnresearchcommunity

for

Search:↓

Occipital hair follicles in male pattern baldness respond uniquely to testosterone, not androgen-insensitive.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tanshinone IIA helps protect tissue from low oxygen damage by activating certain cell pathways.

FFA has higher long-term remission rates than LPP.

Introducing the rat OTC gene partially corrected OTC deficiency in mice.

p2y5, now called LPA6, is a receptor important for human hair growth.

Stem cell transplantation shows promise for treating diseases but faces challenges like safety, ethics, and cost.

PCOS is a hereditary disorder that can lead to diabetes and heart disease if not treated early.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

A man regrew hair after using a 2% fluorouracil treatment on his scalp.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Moderate facial angiofibroma significantly reduces quality of life compared to almost-clear cases, highlighting the benefits of treatment.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Intralesional triamcinolone acetonide helps regrow eyebrows in patients with frontal fibrosing alopecia.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Bimatoprost treats glaucoma and promotes hair growth, with potential for more medical uses.

Lack of Ctip2 in skin cells delays wound healing and disrupts hair follicle stem cell markers in mice.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The Itpr3 gene causes a specific hair pattern in mice.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Forensic DNA phenotyping can now predict more physical traits and ancestry from DNA, but further improvements are needed.